Products with
Anti-hyperlipidemic bioactivity
Cat.No.
|
Product Name
|
BCN3646 |
Dehydroeburicoic acid
|
1. Dehydroeburicoic acid treatment resulted in a marked decrease of tumor weight and size without any significant decrease in mice body weights.
2. Dehydroeburicoic acid induces necrotic cell death that involves Ca(2+) overload, mitochondrial dysfunction, and calpain activation in human glioblastomas.
3. Dehydroeburicoic acid and Eburicoic acid have antioxidant and anti-inflammatory activities by the decrease of inflammatory cytokines and an increase of antioxidant enzyme activity, can protect the liver from CCl4-induced hepatic damage. |
BCN3669 |
Tilianin
|
1. Tilianin has anti-inflammatory activity.
2. Tilianin has antiatherogenic activity.
3. Tilianin inhibits the tumor necrotic factor-K (TNF-K)-induced expression of VCAM-1 by 74% and reduces TNF-K-induced activation of nuclear factor-UB in cultured human umbilical vein endothelial cells (HUVECs).
4. Tilianin has antihypertensive and vasorelaxant activities, mediates relaxation and antihypertension mainly by an endothelium-dependent manner, probably due to NO release, and also through an endothelium-independent pathway by opening K+ channels. |
BCN3681 |
Galangin 3-methyl ether
|
1. Galangin-3-methylether has antibacterial activity, it has inhibitory effects on Pseudomonas aeruginosa.
2. 3-Methylethergalangin has hypolipidemic activity, the action is due to the inhibition of pancreatic lipase. |
BCN3720 |
Gama-Tocotrienol
|
1. Gamma-Tocotrienol has antioxidant activity, it as a hypocholesterolemic and antioxidant agent in rats fed atherogenic diets.
2. Gamma-Tocotrienol can induce the apoptosis on human gastric cancer SGC-7901 cells via mitochondria-dependent apoptosis pathway, it may as a potential, new chemopreventive agent for human gastric cancer.
3. Gamma-Tocotrienol is a novel blocker of the STAT3 activation pathway, with a potential role in future therapies for HCC and other cancers. |
BCN3831 |
Incensole
|
Incensole has a protective or stimulating effect on β-cells of the rat pancreas, it also can increase the insulin secretion, which evidenced by a significant increase both in body weight and in liver glycogen. |